$FUL

Fuller (FUL) Q3 2026 Earnings Call Transcript

Fuller (FUL) reported Q3 2026 net revenue of $938M, up 5.2% YoY, with adjusted EBITDA of $187M, up 9% YoY. Adjusted EPS rose 21% to $1.52. Organic revenue grew 4.4%, driven by pricing. Guidance for fiscal 2026 adjusted EBITDA and EPS was updated. Management highlighted Project Quantum Leap savings and the pending AMS acquisition. Risks include chip shortages and supply chain disruptions.

Original reporting
Published Sep 24, 2026, 9:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 10:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Fuller (FUL) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$FULBullishMed
01

Why it matters

The earnings beat and guidance raise expectations for FY performance, but execution risk around the AMS acquisition and supply-chain volatility could affect outcomes.

02

Market read

Earnings and guidance provide actionable insight for investors; sector peers may be impacted by similar pricing and restructuring trends.

03

What to watch

Potential slowdown in electronics demand and geopolitical supply-chain disruptions remain downside risks.

Relevance 8/10Novelty 8/10Timing: post-earnings release

Background

H.B. Fuller reported Q3 2026 results, showing revenue growth, margin expansion, and updated FY guidance, while outlining restructuring and acquisition plans.

Company-level read

Ticker impact

$FULBullishHigh confidence
Context

Q3 2026 earnings release with revenue, EBITDA, EPS numbers and updated FY guidance.

Expected impact

Potential price appreciation if market digests higher guidance and margin expansion.

Evidence & confidence

Guidance lift and improved profitability are material new information for investors.

Market effects

Adhesives sector may see renewed interest due to pricing power and restructuring trends.

Positive outlook for Europe and EIMEA segments could lift regional peers.

Highlights supply-chain dislocation risks affecting broader industrial markets.

Counterpoint

Restructuring costs and integration risk of the Advanced Medical Solutions acquisition could pressure margins.

Key entities

  • H.B. Fuller Company

    Adhesives manufacturer reporting Q3 2026 earnings.

  • Advanced Medical Solutions

    Pending acquisition target in medical adhesives.

Related articles

$FULHighAI 8/10

Is H.B. Fuller (FUL) Stock a Bargain After Q3 Earnings?

H.B. Fuller (FUL) reported Q3 revenue of $938M, up 5.2% YoY, with adjusted EPS surging 21%. The company raised full-year guidance, citing margin expansion and cost savings. However, sales volume declined 3%, raising concerns about demand. The stock trades at a forward P/E of 9.44x, reflecting mixed investor sentiment.

$FULMedAI 8/10

Why H.B. Fuller Stock Dipped on Thursday

H.B. Fuller (FUL) reported Q3 2026 net revenue of $938M, up 5% YoY, driven by a 7% price increase offsetting volume declines. GAAP net income rose 18% to $79.2M, and adjusted EPS beat estimates at $1.52. However, revenue missed expectations. The company maintained full-year revenue growth guidance and narrowed adjusted EPS guidance to $4.70-$4.85. Shares dipped slightly on the mixed results.

$FULHigh

FULLER H B CO (FUL): Results of Operations and Financial Condition

FULLER H B CO (FUL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Worldwide Headquarters 1200 Willow Lake Boulevard St. Paul, Minnesota 55110-5101 Scott Jensen Investor Relations Contact investors@hbfuller.com NEWS September 23, 2026 H.B. Fuller Reports Third Quarter 2026 Results Net revenue of $938 million, up 5.2% year-on-year; O